While Ozempic is effective for weight loss, it is important to be aware of its potential side effects on muscle and bone health
During a 48-week phase 2 obesity trial, patients on weekly doses of Retatrutide (8 mg and 12 mg) had average body weight losses of 22.8% and 24.2%, respectively
Nausea, vomiting, diarrhoea, constipation, and abdominal pain are experienced by a substantial proportion of patients, particularly during dose escalation
Prioritize suppliers offering volume discounts beyond 1,000 units
One exclusion is drugs used for anorexia, weight gain, or weight loss (even if used for a non-cosmetic purpose (i.e., morbid obesity). What is being done: In June, the House Ways and Means Committee took a baby step toward reversing this exclusion